Abreva, the first OTC product approved to speed HEALING of cold sores and fever blisters

November 2000

SmithKline is now marketing Abreva, the first OTC product approved to speed HEALING of cold sores and fever blisters.

The other OTCs for cold sores are approved only to treat SYMPTOMS.

Abreva shortens the duration of cold sores about as well as the Rx antiviral creams...Zovirax (acyclovir) and Denavir (penciclovir).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

pharmacists as part of an "early warning system" to help identify problems with newly approved drugs
Oral Health Abreva, the first OTC product approved to speed HEALING of cold sores and fever blisters
Cardiology more patients taking ACE inhibitors
Osteoporosis new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
Osteoporosis treating osteoporosis in MEN
Osteoporosis Lead contamination in calcium supplements
Diabetes Glucophage XR, a new extended-release metformin tablet for once-a-day dosing
OTC Products Experts are now urging the FDA to ban the use of phenylpropanolamine (PPA) in OTC products
OTC Products Mercury thermometers will soon be a thing of the past
Influenza It turns out there WILL be enough flu vaccine to go around this season
Influenza Tamiflu is more effective if it's started earlier
Hematology & Oncology Trisenox, an injectable form of ARSENIC
Qvar (CUE-var) beclomethasone inhaler for asthma
inhaled steroids DON'T affect LONG-TERM growth in children
community pharmacy residencies
Women's Health new injectable contraceptive called Lunelle
OTC Products Pepcid Complete, the first H2-blocker and antacid combo for heartburn.
Ophthalmology Quixin, a new levofloxacin eye drop for conjunctivitis.
new ways to manage hypersexuality in dementia patients